{"id":"placebo-oral-vial","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effect (adverse events attributed to placebo expectation)"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo oral vial","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:02:49.843490+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T04:03:03.182210+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:02:54.944734+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo oral vial","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:02:55.298675+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108778/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:02:56.234212+00:00"}},"_dailymed":null,"aiSummary":"Placebo oral vial, marketed by Federico II University, holds a unique position in the pharmaceutical market as a non-active substance used primarily in clinical trials. The key composition patent for Placebo oral vial is set to expire in 2028, which may provide a period of exclusivity and competitive advantage. However, the lack of a defined primary indication and revenue data poses a significant risk in assessing its market impact and potential competition.","mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials and sometimes therapeutically to leverage psychobiological mechanisms such as expectation, conditioning, and the mind-body interaction. It has no direct molecular or pharmacological action but can elicit measurable clinical responses in certain conditions, particularly those with subjective symptom components or high psychological influence.","oneSentence":"Placebo contains no active pharmaceutical ingredient and produces therapeutic effects primarily through the placebo effect—the patient's expectation of benefit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:18.059Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T04:03:03.182292+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Clinical trial control arm (non-therapeutic use)"},{"name":"Conditions responsive to placebo effect (e.g., pain, nausea, fatigue) in research settings"}]},"trialDetails":[{"nctId":"NCT06676319","phase":"PHASE2","title":"Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-11-07","conditions":"Asthma","enrollment":1147},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT07207954","phase":"PHASE1","title":"Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Lifordi Immunotherapeutics, Inc.","startDate":"2025-10-06","conditions":"Rheumatoid Arthritis","enrollment":176},{"nctId":"NCT05488340","phase":"PHASE2","title":"A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)","status":"RECRUITING","sponsor":"Locus Biosciences","startDate":"2022-07-13","conditions":"Urinary Tract Infections","enrollment":318},{"nctId":"NCT07450430","phase":"PHASE3","title":"Optimal Timing of Ketamine Initiation for SCD Pain","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-02","conditions":"Sickle Cell Disease, Sickle Cell Crisis","enrollment":90},{"nctId":"NCT05674994","phase":"PHASE3","title":"Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2023-10-26","conditions":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":110},{"nctId":"NCT07439419","phase":"PHASE1","title":"DBM-1152A Inhalation Solution in Healthy Volunteers","status":"COMPLETED","sponsor":"Joincare Pharmaceutical Group Industry Co., Ltd","startDate":"2024-08-18","conditions":"Healthy","enrollment":20},{"nctId":"NCT05712200","phase":"PHASE3","title":"Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)","status":"RECRUITING","sponsor":"Anthos Therapeutics, Inc.","startDate":"2022-12-27","conditions":"Atrial Fibrillation (AF)","enrollment":1900},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT07298408","phase":"PHASE1, PHASE2","title":"Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Florida A&M University","startDate":"2026-01-02","conditions":"Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies","enrollment":20},{"nctId":"NCT07326995","phase":"PHASE2","title":"Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma","status":"RECRUITING","sponsor":"Anhui Palo Alto Pharmaceuticals, Inc.","startDate":"2025-02-24","conditions":"Bronchial Asthma","enrollment":60},{"nctId":"NCT07300813","phase":"NA","title":"Olistic_2025 for Hair Loss, Hair Growth, and Skin Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bionos Biotech S.L.","startDate":"2025-10-20","conditions":"Hair Care, Hair Loss, Female Pattern Hair Loss","enrollment":100},{"nctId":"NCT05846399","phase":"PHASE4","title":"CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)","status":"RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2023-09-07","conditions":"Cat Bite, Hand Injuries, Arm Injury","enrollment":72},{"nctId":"NCT04268849","phase":"PHASE3","title":"Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient","status":"RECRUITING","sponsor":"Auerbach Hematology Oncology Associates P C","startDate":"2020-02-27","conditions":"Iron Deficiency Anemia","enrollment":104},{"nctId":"NCT07179237","phase":"PHASE2","title":"Efficacy of Carminal in Helicobacter Pylori Gastritis","status":"RECRUITING","sponsor":"Catalysis SL","startDate":"2025-08-04","conditions":"H Pylori Gastritis, H Pylori Infection, H Pylori Eradication","enrollment":80},{"nctId":"NCT05710575","phase":"NA","title":"Role of Probiotic Use in Outcomes of Premature Birth","status":"COMPLETED","sponsor":"University of Health Sciences Lahore","startDate":"2023-02-20","conditions":"Necrotizing Enterocolitis of Newborn","enrollment":100},{"nctId":"NCT07020429","phase":"NA","title":"Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2025-09-01","conditions":"Premature Ovarian Insufficiency","enrollment":276},{"nctId":"NCT07157748","phase":"NA","title":"Effects of Compound Ejiao Syrup on Exercise Tolerance and Quality of Life in Critically Ill Patients After ICU Discharge: A Double-Blind, Multicenter,Randomized Controlled Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Third Military Medical University","startDate":"2025-12","conditions":"Critically Ill Patients","enrollment":178},{"nctId":"NCT06131021","phase":"PHASE3","title":"Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-04-25","conditions":"Periodontitis, Periodontal Diseases, Periodontal Pocket","enrollment":150},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT03365622","phase":"PHASE4","title":"Efficacy of IV Acetaminophen Versus Oral Acetaminophen","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2018-08-08","conditions":"Nephrectomy","enrollment":214},{"nctId":"NCT05717062","phase":"PHASE2","title":"Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)","status":"COMPLETED","sponsor":"Ophirex, Inc.","startDate":"2023-05-30","conditions":"Snakebite, Envenoming, Snake","enrollment":140},{"nctId":"NCT04870333","phase":"PHASE2, PHASE3","title":"PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2021-02-19","conditions":"Covid19","enrollment":2240},{"nctId":"NCT04721691","phase":"PHASE1","title":"Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2021-03-10","conditions":"Electrical Status Epilepticus of Slow-Wave Sleep","enrollment":16},{"nctId":"NCT06989567","phase":"PHASE3","title":"A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis","status":"NOT_YET_RECRUITING","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2025-07-25","conditions":"Sickle Cell Disease","enrollment":120},{"nctId":"NCT02839915","phase":"PHASE2","title":"Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Southwest Autism Research & Resource Center","startDate":"2020-08-13","conditions":"Autism Spectrum Disorder","enrollment":56},{"nctId":"NCT05976698","phase":"NA","title":"LSD-Perceptual-Choice-Study","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-02-26","conditions":"LSD Reaction","enrollment":30},{"nctId":"NCT06865261","phase":"NA","title":"Effects of L-ARGinine and Liposomal Vitamin C Supplementation On Physical Performance","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-05-20","conditions":"Sarcopenia","enrollment":100},{"nctId":"NCT06766825","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)","status":"RECRUITING","sponsor":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","startDate":"2025-02-07","conditions":"Post COVID-19 Condition, Long COVID Syndrome, Persistent COVID-19","enrollment":90},{"nctId":"NCT03781128","phase":"PHASE2","title":"Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-01-02","conditions":"Cluster Headache","enrollment":30},{"nctId":"NCT05895838","phase":"PHASE3","title":"The Danish Out-of-Hospital Cardiac Arrest Study","status":"RECRUITING","sponsor":"Christian Hassager","startDate":"2023-06-16","conditions":"Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome","enrollment":1000},{"nctId":"NCT05212662","phase":"PHASE2","title":"Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19","status":"WITHDRAWN","sponsor":"Thiogenesis Therapeutics, Inc.","startDate":"2024-09-27","conditions":"COVID-19, COVID-19 Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT04058028","phase":"PHASE2","title":"Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","sponsor":"Amgen","startDate":"2020-02-19","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":244},{"nctId":"NCT04315948","phase":"PHASE3","title":"Trial of Treatments for COVID-19 in Hospitalized Adults","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2020-03-22","conditions":"Corona Virus Infection","enrollment":1552},{"nctId":"NCT03672292","phase":"PHASE2","title":"Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis","status":"TERMINATED","sponsor":"Scynexis, Inc.","startDate":"2019-01-22","conditions":"Invasive Pulmonary Aspergillosis","enrollment":22},{"nctId":"NCT05864716","phase":"NA","title":"Colonoscopic Probiotics Spray in Irritable Bowel Syndrome","status":"NOT_YET_RECRUITING","sponsor":"National Cheng-Kung University Hospital","startDate":"2024-10-01","conditions":"Effect of Drug","enrollment":66},{"nctId":"NCT06502834","phase":"PHASE1","title":"Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)","status":"RECRUITING","sponsor":"Max Nieuwdorp","startDate":"2024-05-01","conditions":"Obesity, Metabolic Syndrome, Steatosis of Liver","enrollment":20},{"nctId":"NCT06374043","phase":"PHASE4","title":"Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2021-05-11","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus Type 2 With Proteinuria, Diabetes Mellitus","enrollment":20},{"nctId":"NCT03980483","phase":"PHASE3","title":"Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-05-16","conditions":"Arthritis, Rheumatoid","enrollment":1537},{"nctId":"NCT06250400","phase":"PHASE4","title":"Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)","status":"UNKNOWN","sponsor":"Hangzhou Grand Biologic Pharmaceutical, Inc.","startDate":"2024-03-31","conditions":"Chronic Spontaneous Urticaria","enrollment":252},{"nctId":"NCT05916911","phase":"PHASE4","title":"Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)","status":"UNKNOWN","sponsor":"Catalysis SL","startDate":"2023-06-07","conditions":"Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion","enrollment":120},{"nctId":"NCT02499354","phase":"PHASE2","title":"Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)","status":"COMPLETED","sponsor":"Auerbach Hematology Oncology Associates P C","startDate":"2014-08","conditions":"Restless Legs Syndrome, Iron Deficiency Anemia","enrollment":100},{"nctId":"NCT06200883","phase":"PHASE4","title":"Effects of a Nutraceutic Compound on Cognitive Impairment","status":"COMPLETED","sponsor":"Federico II University","startDate":"2022-09-01","conditions":"Mild Cognitive Impairment","enrollment":58},{"nctId":"NCT03491540","phase":"PHASE3","title":"Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer Surgery","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-09-03","conditions":"Rectal Cancer Surgery","enrollment":414},{"nctId":"NCT03970837","phase":"PHASE3","title":"Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2019-06-05","conditions":"Arthritis, Rheumatoid","enrollment":1764},{"nctId":"NCT04939545","phase":"PHASE3","title":"Study of Postoperative ICC Analgesia","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-12-15","conditions":"Postoperative Analgesia","enrollment":32},{"nctId":"NCT02204982","phase":"PHASE3","title":"Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma","status":"TERMINATED","sponsor":"SecuraBio","startDate":"2014-09","conditions":"Follicular Lymphoma","enrollment":13},{"nctId":"NCT02760368","phase":"PHASE3","title":"Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease","status":"COMPLETED","sponsor":"R-Pharm International, LLC","startDate":"2016-05-19","conditions":"Rheumatoid Arthritis","enrollment":428},{"nctId":"NCT02760433","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease","status":"COMPLETED","sponsor":"R-Pharm International, LLC","startDate":"2017-01-25","conditions":"Rheumatoid Arthritis","enrollment":368},{"nctId":"NCT02760407","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease","status":"COMPLETED","sponsor":"R-Pharm International, LLC","startDate":"2016-06-06","conditions":"Rheumatoid Arthritis","enrollment":1648},{"nctId":"NCT02499120","phase":"PHASE2","title":"Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer","status":"COMPLETED","sponsor":"Pfizer","startDate":"2015-09-10","conditions":"Squamous Cell Carcinoma of the Head and Neck (SCCHN)","enrollment":125},{"nctId":"NCT05863286","phase":"NA","title":"Assessment of Botulinum Toxin Injection for Treatment of Temporomandibular Joint Dislocation","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-12-30","conditions":"Dislocation of Temporomandibular Joint TMJ, Subluxation of Temporomandibular Joint","enrollment":28},{"nctId":"NCT03997097","phase":"PHASE3","title":"Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease","status":"WITHDRAWN","sponsor":"University Hospital, Montpellier","startDate":"2023-06-01","conditions":"Single-ventricle, Pulmonary Hypertension, Univentricular Heart","enrollment":""},{"nctId":"NCT01478035","phase":"PHASE4","title":"Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.","status":"TERMINATED","sponsor":"M. Carmen Cabellos Minguez","startDate":"2011-11","conditions":"Seizures, Pneumococcal Meningitis","enrollment":26},{"nctId":"NCT01086540","phase":"PHASE2","title":"Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-06-24","conditions":"Systemic Sclerosis-Associated PAH","enrollment":57},{"nctId":"NCT04626375","phase":"PHASE4","title":"Effects of L-arginine on Myocardial Energetic Efficiency and Global Longitudinal Strain","status":"COMPLETED","sponsor":"Federico II University","startDate":"2020-09-14","conditions":"Myocardial Dysfunction","enrollment":54},{"nctId":"NCT03475680","phase":"PHASE3","title":"Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-08-08","conditions":"Colon Cancer","enrollment":193},{"nctId":"NCT05345912","phase":"PHASE1","title":"Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults","status":"COMPLETED","sponsor":"CrystalGenomics, Inc.","startDate":"2019-12-16","conditions":"Healthy","enrollment":24},{"nctId":"NCT03581734","phase":"PHASE3","title":"Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine","status":"UNKNOWN","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2018-07-01","conditions":"Vaccine Reaction","enrollment":579},{"nctId":"NCT02910635","phase":"PHASE1","title":"A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers","status":"COMPLETED","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2016-09-19","conditions":"Abnormalities, Cardiovascular","enrollment":52},{"nctId":"NCT03400033","phase":"PHASE3","title":"Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-09-05","conditions":"Anaemia","enrollment":407},{"nctId":"NCT04915963","phase":"PHASE3","title":"Vitamin D Supplementation in Intensive Care Unit Patients","status":"COMPLETED","sponsor":"Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose","startDate":"2016-01-20","conditions":"Dietary Supplements, Intensive Care Unit, Vitamin D Deficiency","enrollment":340},{"nctId":"NCT04883203","phase":"PHASE3","title":"The Effect of Vitamin D Supplementation on COVID-19 Recovery","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2020-04-22","conditions":"Covid19","enrollment":130},{"nctId":"NCT03078075","phase":"PHASE3","title":"Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2017-05-05","conditions":"Methamphetamine Use Disorder","enrollment":403},{"nctId":"NCT03524651","phase":"PHASE4","title":"Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.","startDate":"2018-05-02","conditions":"Iron Deficiency Anemia","enrollment":60},{"nctId":"NCT02576275","phase":"PHASE3","title":"A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)","status":"WITHDRAWN","sponsor":"SecuraBio","startDate":"2015-12","conditions":"Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma","enrollment":""},{"nctId":"NCT04637906","phase":"NA","title":"Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2)","status":"UNKNOWN","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2020-11-18","conditions":"Covid19","enrollment":290},{"nctId":"NCT01789216","phase":"PHASE3","title":"Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2013-07","conditions":"Orthopaedic Fractures","enrollment":450},{"nctId":"NCT04658732","phase":"PHASE1","title":"A Comparative Study of Oral Gabapentin, Oral Alprazolam and Intravenous Dexmedetomidine on Perioperative Anxiety and Pain During Posterior Segment Eye Surgery Under Peribulbar Block : a Randomized, Double-blind Study.","status":"UNKNOWN","sponsor":"Ehab Tarek Fahmy","startDate":"2020-12-01","conditions":"Sedation for Patients Undergoing Peribulbar Block","enrollment":45},{"nctId":"NCT04512482","phase":"PHASE2","title":"Evaluation of Oral Plaque Removal Utilizing an Adjunct Enzyme Pre-rinse","status":"COMPLETED","sponsor":"Indiana University","startDate":"2018-06-14","conditions":"Dental Plaque, Dental Caries","enrollment":46},{"nctId":"NCT02927431","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-01-19","conditions":"Virus Diseases","enrollment":10},{"nctId":"NCT02221037","phase":"PHASE2","title":"Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2015-04-28","conditions":"Lung Injury, Acute and Respiratory Distress Syndrome, Adult","enrollment":35},{"nctId":"NCT04461353","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Pulmoquine Therapeutics, Inc","startDate":"2020-06-25","conditions":"Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":12},{"nctId":"NCT03210519","phase":"NA","title":"To Evaluate the Efficacy of Eleutherococcus Senticosus for Subjects Under Renal Dialysis","status":"COMPLETED","sponsor":"Chung Shan Medical University","startDate":"2015-12-09","conditions":"Renal Dialysis","enrollment":21},{"nctId":"NCT01980992","phase":"PHASE1, PHASE2","title":"Oral Immunotherapy for Wheat Allergy","status":"COMPLETED","sponsor":"Hugh A Sampson, MD","startDate":"2013-10","conditions":"Wheat Allergy","enrollment":46},{"nctId":"NCT01757899","phase":"PHASE2","title":"Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children","status":"WITHDRAWN","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2014-01","conditions":"Acute Lung Injury, Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT02984397","phase":"PHASE3","title":"Chronic Widespread Pain and White Blood Cell Activation","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2016-12","conditions":"Widespread Chronic Pain","enrollment":44},{"nctId":"NCT03701984","phase":"PHASE4","title":"The Effect of Intrauterine Lidocaine Infusion and Oral Tramadol on Pain During Diagnostic Office Hysteroscopy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-10-15","conditions":"Hysteroscopy","enrollment":156},{"nctId":"NCT02426918","phase":"PHASE2","title":"Study of Debio 1450 for Bacterial Skin Infections","status":"COMPLETED","sponsor":"Debiopharm International SA","startDate":"2015-05","conditions":"Bacterial Infections","enrollment":330},{"nctId":"NCT03777514","phase":"NA","title":"Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2019-08","conditions":"IDA in the Post-bariatric Surgical Patient","enrollment":""},{"nctId":"NCT03234452","phase":"NA","title":"Evaluation of the Beneficial Effects of a Probiotic Product in Healthy Adult Subjects.","status":"COMPLETED","sponsor":"Montefarmaco OTC SpA","startDate":"2016-03-23","conditions":"Disbiosis, Abdominal Pain, Constipation","enrollment":50},{"nctId":"NCT04038853","phase":"PHASE4","title":"Vitamin D in Fatty Liver Disease","status":"COMPLETED","sponsor":"University Hospital Rijeka","startDate":"2015-12-01","conditions":"Non-alcoholic Fatty Liver Disease, Vitamin D Deficiency","enrollment":360},{"nctId":"NCT03833362","phase":"PHASE3","title":"Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)","status":"COMPLETED","sponsor":"R-Pharm","startDate":"2014-05-07","conditions":"Hepatitis C","enrollment":420},{"nctId":"NCT01818011","phase":"PHASE1","title":"A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2013-08-07","conditions":"Infections, Bacterial","enrollment":12},{"nctId":"NCT01258608","phase":"PHASE1, PHASE2","title":"Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma","status":"COMPLETED","sponsor":"Human Genome Sciences Inc., a GSK Company","startDate":"2011-02-08","conditions":"Carcinoma, Hepatocellular","enrollment":101},{"nctId":"NCT01980888","phase":"PHASE3","title":"Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2014-02-05","conditions":"Chronic Lymphocytic Leukemia","enrollment":311},{"nctId":"NCT01732926","phase":"PHASE3","title":"Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2013-01-02","conditions":"Indolent Non-Hodgkin's Lymphomas","enrollment":475},{"nctId":"NCT01231620","phase":"PHASE3","title":"A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-01-15","conditions":"Influenza, Human","enrollment":626},{"nctId":"NCT01732458","phase":"PHASE2","title":"A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2013-02-12","conditions":"Post-operative Nausea, Post-operative Vomiting","enrollment":229},{"nctId":"NCT00819585","phase":"PHASE2","title":"A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-12","conditions":"Gout","enrollment":432},{"nctId":"NCT02027207","phase":"PHASE3","title":"Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2012-12-09","conditions":"Cholera","enrollment":204438},{"nctId":"NCT03468842","phase":"PHASE1","title":"Study to Evaluate the Clinical Efficacy of Streptococcus Dentisani CECT 7746 in Caries Risk Reduction","status":"COMPLETED","sponsor":"AB Biotics, SA","startDate":"2016-05-13","conditions":"Caries","enrollment":76},{"nctId":"NCT02796651","phase":"PHASE2","title":"Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2016-06-30","conditions":"Chronic Obstructive Pulmonary Disease - COPD","enrollment":132},{"nctId":"NCT02336425","phase":"PHASE2","title":"Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2015-09","conditions":"Asthma","enrollment":10},{"nctId":"NCT01007435","phase":"PHASE3","title":"A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2009-10-31","conditions":"Rheumatoid Arthritis","enrollment":1162},{"nctId":"NCT01962454","phase":"PHASE1","title":"A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-05-05","conditions":"Cachexia","enrollment":20},{"nctId":"NCT00346398","phase":"PHASE2","title":"Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-05","conditions":"Asthma, Allergic Sensitization","enrollment":51},{"nctId":"NCT01899768","phase":"PHASE2","title":"GSK2339345 Hypertussive Challenge Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-11","conditions":"Cough","enrollment":16},{"nctId":"NCT01994291","phase":"PHASE2","title":"A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema","status":"TERMINATED","sponsor":"Pfizer","startDate":"2013-11","conditions":"Macular Edema, Diabetic","enrollment":199},{"nctId":"NCT01050114","phase":"PHASE3","title":"OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER","status":"UNKNOWN","sponsor":"Christopher Patrick Smith","startDate":"2013-08","conditions":"Overactive Bladder","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL2108778"},"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo oral vial","genericName":"Placebo oral vial","companyName":"Federico II University","companyId":"federico-ii-university","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T04:03:03.182292+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}